FDC Limited Stock NSE India S.E.

Equities

FDC

INE258B01022

Pharmaceuticals

Delayed NSE India S.E. 12:42:30 2024-05-06 am EDT 5-day change 1st Jan Change
445 INR -0.81% Intraday chart for FDC Limited -3.60% +12.25%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 15.28B 183M Sales 2023 17.84B 214M Capitalization 42.56B 510M
Net income 2022 2.16B 25.94M Net income 2023 1.94B 23.26M EV / Sales 2022 2.51 x
Net cash position 2022 5.06B 60.69M Net cash position 2023 4.53B 54.29M EV / Sales 2023 2.13 x
P/E ratio 2022
20 x
P/E ratio 2023
22 x
Employees 6,372
Yield 2022 *
-
Yield 2023
-
Free-Float 30.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.81%
1 week-3.60%
Current month-1.86%
1 month-1.12%
3 months+2.80%
6 months+23.44%
Current year+12.25%
More quotes
1 week
439.15
Extreme 439.15
464.35
1 month
439.15
Extreme 439.15
468.70
Current year
392.00
Extreme 392
487.70
1 year
282.05
Extreme 282.05
487.70
3 years
225.00
Extreme 225
487.70
5 years
151.20
Extreme 151.2
487.70
10 years
117.00
Extreme 117
487.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 88 67-04-20
Chief Executive Officer 61 93-09-29
Director of Finance/CFO - 23-04-05
Members of the board TitleAgeSince
Chief Executive Officer 61 93-09-29
Director/Board Member - 99-12-31
Chief Executive Officer 88 67-04-20
More insiders
Date Price Change Volume
24-05-06 445 -0.81% 44 875
24-05-03 448.6 +0.41% 78,849
24-05-02 446.8 -1.47% 60,549
24-04-30 453.4 -1.77% 91,740
24-04-29 461.6 +1.07% 206,001

Delayed Quote NSE India S.E., May 06, 2024 at 12:42 am EDT

More quotes
FDC Limited is an India-based company, which is principally engaged in the business of pharmaceuticals. The Company manufactures and distributes its range of generics, formulations, and active pharmaceuticals at its manufacturing plants. It also manufactures oral rehydration salts (ORS) and specialized formulations. It has a range of functional foods and beverages. Its active pharmaceutical ingredients (APIs) include Albuterol Sulfate, Bromhexine Hydrochloride, Cinnarizine, Flunarizine Dihydrochloride, Flurbiprofen, Flurbiprofen Sodium, Miconazole Nitrate and Timolol Maleate, among others. It has its presence in various therapeutic segments, such as anti-infectives, gastrointestinal, ophthalmological, vitamins/ minerals/ dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others. Its various brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl and Mycoderm.
More about the company

Quarterly revenue - Rate of surprise

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW